Six posters highlight continued progress across antibody-drug conjugate and T cell engager platforms Novel T cell engager ZW209 demonstrates durable activity in small cell lung cancer; IND submission expected in… Read More
EDMONTON, AB – The Alberta Cancer Foundation and Hoffmann-La Roche Limited (Roche Canada) have announced a new partnership that will see the global life sciences company redirect $1 million of its… Read More
VANCOUVER, BC — Kardium Inc., a private medical device company that’s advancing the way the world treats atrial fibrillation (AF), announced late-breaking, one-year clinical trial results for its innovative pulsed… Read More
Augurex to attend British Society for Rheumatology 2025 Annual Meeting in Manchester, UK Highlighting biomarker-based diagnostic innovations for RA and axSpA VANCOUVER, BC – Augurex Life Sciences Corp., a leader… Read More
VANCOUVER, BC – Optigo Biotherapeutics (Optigo), a preclinical-stage biotechnology company focused on discovering and developing transformative therapies for blinding neovascular diseases, announced their presentation of data related to their long-acting… Read More
